+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Infant Formula Ingredients Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 185 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904867
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The infant formula ingredients market is characterized by swift innovation and growing regulatory focus as leading manufacturers, policymakers, and nutrition experts respond to evolving consumer and compliance expectations. Senior decision-makers must address rising complexity driven by advancements in product formulation, transparency standards, and supply chain management challenges.

Market Snapshot: Growth and Opportunities in the Infant Formula Ingredients Market

The infant formula ingredients market grew from USD 27.48 billion in 2024 to USD 30.12 billion in 2025 and is projected to reach USD 56.63 billion by 2032, reflecting an impressive CAGR of 9.45%. This trajectory underscores expanding worldwide demand for high-quality, safe, and scientifically advanced inputs for infant nutrition. Both established and developing regions are seeing sharp increases in expectations for product differentiation, functional advances, and comprehensive compliance as consumer and stakeholder priorities shift. Expanded ingredient science and more stringent standards play pivotal roles in shaping purchase decisions, strategies for innovation, and conditions for new market entry across the sector.

Scope & Segmentation of the Market

This report evaluates core market segments, regulatory implications, and emerging product trends shaping the global infant formula ingredients landscape:

  • Protein Source: Cow milk protein, goat milk protein, extensive hydrolysate, partial hydrolysate, and soy protein ingredient options allow brands to cater to varied dietary needs and sensitivities common among infants.
  • Form: Concentrated liquids, powders (offered in pouch, sachet, or tin), and ready-to-drink alternatives (bottle or Tetra Pak) support diverse consumer preferences in preparation and convenience.
  • Organic Status: Both conventional and certified organic formulations—covering EU organic and USDA organic—address demand for natural and traceable infant nutrition.
  • Additives: Enriched with DHA/ARA, micronutrient fortification, prebiotic fibers (fructo-oligosaccharide, galacto-oligosaccharide), and proven probiotics, formulations are tailored to promote advanced health and developmental milestones.
  • Lactose Content: Both lactose-based and lactose-free options support dietary flexibility, accommodating sensitivities or intolerance as part of inclusive product ranges.
  • Geographic Coverage: Analysis spans key regions including the Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (e.g., United Kingdom, Germany, France, UAE, Saudi Arabia, South Africa, Kenya), and Asia-Pacific (e.g., China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan), enabling tailored market strategies for each territory.
  • Key Companies: Coverage includes operations and strategies of major industry participants: Fonterra Co-operative Group Limited, Arla Foods amba, Royal DSM N.V., Royal FrieslandCampina N.V., Kerry Group plc, Glanbia plc, Archer-Daniels-Midland Company, Cargill, Incorporated, BASF SE, and Tate & Lyle PLC.

Key Takeaways for Senior Decision-Makers

  • Innovative ingredient technologies are narrowing the gap between formula and breast milk, supporting improved nutritional profiles and health outcomes.
  • The push for transparent labeling and verified sourcing is intensifying, driving broader adoption of organic and ethical supply chain protocols among multinational and regional players.
  • Heightened global regulatory requirements are prompting industry leaders to invest in proactive compliance systems and reformulation to align with evolving international standards.
  • Supply chain resilience is becoming essential as businesses contend with market disruptions, prompting shifts toward domestic partners and flexible sourcing strategies.
  • Each global region presents unique regulatory and consumer challenges, requiring localized approaches to product positioning and compliance to maximize market reach.

Examining the Impact of United States Tariffs on Supply Chains

Recent U.S. tariffs introduced in 2025 are reshaping supply chain strategies for ingredient procurement. To counteract increased costs and complexity, many manufacturers are revisiting supplier relationships, prioritizing domestic sourcing where possible, and strengthening risk management protocols to ensure margin protection and operational continuity.

Methodology & Data Sources

This analysis is based on a rigorous methodology that combines in-depth interviews with nutrition science, regulatory, and supply chain experts with thorough review of secondary data, including regulatory filings, clinical studies, and company reports. Peer review supports the reliability and practical value of all insights delivered.

Why This Report Matters

  • Facilitates strategic decision-making by benchmarking current business approaches against global market and regulatory shifts in the infant formula ingredients market.
  • Provides actionable intelligence on innovation, competition, and supply chain realignments across priority regional markets.
  • Guides organizations to effectively address risks and capitalize on opportunities amid fluctuating trade and compliance environments.

Conclusion

This research enables industry leaders to set robust strategy by drawing on a detailed assessment of segmentation, technology trends, and policy developments. Sustained monitoring and responsiveness will be key to unlocking growth and meeting evolving market and regulatory expectations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rise of plant-based protein isolates like soy and pea for hypoallergenic formula innovations
5.2. Integration of microencapsulated probiotics and postbiotics to enhance immune support in infant formula
5.3. Development of DHA and ARA from algal and fungal sources to improve neurodevelopment outcomes
5.4. Expansion of tailored formula blends enriched with MFGM components for cognitive development benefits
5.5. Formulation of low-lactose and lactose-free infant formulas to address global lactose intolerance rates
5.6. Use of targeted prebiotic fiber platforms such as GOS and FOS to promote beneficial gut microbiota in infants
5.7. Incorporation of novel plant-derived sterols and phytosterol conjugates to support cholesterol metabolism in infants
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Infant Formula Ingredients Market, by Protein Source
8.1. Cow Milk Protein
8.2. Goat Milk Protein
8.3. Protein Hydrolysate
8.3.1. Extensive Hydrolysate
8.3.2. Partial Hydrolysate
8.4. Soy Protein
9. Infant Formula Ingredients Market, by Form
9.1. Concentrated Liquid
9.2. Powder
9.2.1. Pouch
9.2.2. Sachet
9.2.3. Tin
9.3. Ready To Drink
9.3.1. Bottle
9.3.2. Tetra Pak
10. Infant Formula Ingredients Market, by Organic Status
10.1. Conventional
10.2. Organic
10.2.1. EU Organic
10.2.2. USDA Organic
11. Infant Formula Ingredients Market, by Additives
11.1. Dha Ara Enriched
11.2. Micronutrient Fortified
11.3. Prebiotic Enriched
11.3.1. Fructo Oligosaccharide
11.3.2. Galacto Oligosaccharide
11.4. Probiotic Enriched
11.4.1. Bifidobacterium
11.4.2. Lactobacillus
12. Infant Formula Ingredients Market, by Lactose Content
12.1. Lactose Based
12.2. Lactose Free
13. Infant Formula Ingredients Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Infant Formula Ingredients Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Infant Formula Ingredients Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Fonterra Co-operative Group Limited
16.3.2. Arla Foods amba
16.3.3. Royal DSM N.V.
16.3.4. Royal FrieslandCampina N.V.
16.3.5. Kerry Group plc
16.3.6. Glanbia plc
16.3.7. Archer-Daniels-Midland Company
16.3.8. Cargill, Incorporated
16.3.9. BASF SE
16.3.10. Tate & Lyle PLC
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Infant Formula Ingredients market report include:
  • Fonterra Co-operative Group Limited
  • Arla Foods amba
  • Royal DSM N.V.
  • Royal FrieslandCampina N.V.
  • Kerry Group plc
  • Glanbia plc
  • Archer-Daniels-Midland Company
  • Cargill, Incorporated
  • BASF SE
  • Tate & Lyle PLC

Table Information